Trial Profile
High-Dose Sequential Chemotherapy and Rituximab (R-HDS) in Patients With Systemic B-Cell Lymphoma With Central Nervous System Involvement at Diagnosis or Relapse.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs Cytarabine (Primary) ; Cyclophosphamide; Etoposide; Methotrexate; Rituximab; Thiotepa
- Indications B-cell lymphoma
- Focus Therapeutic Use
- 08 Dec 2008 New trial record.